Dadi International Group Limited — M&A Activity 2011

Feb 1, 2011

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [100 x 100] intentionally omitted <==

XING LIN MEDICAL INFORMATION TECHNOLOGY COMPANY LIMITED 杏林醫療信息科技有限公司[*]

(incorporated in the Cayman Islands and continued in Bermuda with limited liability)

(Stock Code: 8130)

ANNOUNCEMENT

TERMINATION OF ACQUISITION OF EQUITY INTEREST IN REDART DIGITAL TECHNOLOGY CO., LTD.

Reference is made to the announcement of the Company dated 21 January, 2010 regarding the proposed acquisition of a 20% equity interest in Redart Digital Technology Co., Ltd.

The Board announces that on 1 February, 2011, the Purchaser entered into the Deed of Termination with the Vendor whereby all parties mutually agree to terminate the Agreement with immediate effect.

The Board considers that the termination of the Agreement will not have any material adverse impact on the existing business or financials of the Group.

Reference is made to the announcement of the Company dated 21 January, 2010 regarding the proposed acquisition of a 20% equity interest in Redart Digital Technology Co., Ltd. (the “ Announcement ”). Terms used herein shall have the same meanings as defined in the Announcement unless the context otherwise requires.

The Board announces that as certain conditions cannot be fulfilled, on 1 February, 2011, the Purchaser entered into a deed of termination (the “ Deed of Termination ”) with the Vendor whereby all parties mutually agree to terminate the Agreement with immediate effect.

The Board considers that the termination of the Agreement will not have any material adverse impact on the existing business or financials of the Group.

1

The Deposit has been returned to the Purchaser without interest. The Company intends to use the monies from the return of the Deposit for business expansion and other investments and for general working capital purpose. As at the date of this announcement, no acquisition targets have yet been identified.

By Order of the Board Xing Lin Medical Information Technology Company Limited Lien Wai Hung Chairman

Hong Kong, 1 February, 2011

As at the date of this announcement, the executive Director is Lien Wai Hung; the independent nonexecutive Directors are Leung Wai Man, Kwok Chuen Hung, Dominic and Ho Chun Ki, Frederick.

This announcement, for which the Directors collectively and individually accept full responsibilities, includes particulars given in compliance with the Rules Governing the Listing of Securities on the Growth Enterprise Market of The Stock Exchange of Hong Kong Limited for the purpose of giving information with regard to the Company. The Directors, having made all reasonable enquiries, confirm that to the best of their knowledge and belief the information contained in this announcement is accurate and complete in all material respects and not misleading or deceptive, and there are no other matters the omission of which would make any statement herein or this announcement misleading.

This announcement will remain on the “Latest Company Announcements” page of the GEM website at www.hkgem.com for a minimum period of 7 days from the date of its publication and on the Company’s website at www.xinglin-med.com.

• For identification purposes only

2